News search
|
Research 24 Jun 2026 Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration |
|
About the CNIC 23 Jun 2026 CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease |
|
About the CNIC 11 Jun 2026 The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease |
|
Research 21 Apr 2026 CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events. |
|
Research 26 Feb 2026 The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines |
|
Research 10 Feb 2026 The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia |
|
Research 5 Feb 2026 A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction. |
|
Research 2 Feb 2026 A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves |
|
Research 14 Jan 2026 A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered. |
- 1 of 10
- next ›
















